Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity
The identification of effective new therapies for prostate cancer (PCa) requires a better understanding of the multiple molecular interactions between tumor cells and their associated microenvironment. In this context, galectin-1 (Gal-1) is a key molecule in the determination of the prostatic carcin...
Guardado en:
| Publicado: |
2018
|
|---|---|
| Materias: | |
| Acceso en línea: | https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_16643224_v9_n_p2190_Corapi http://hdl.handle.net/20.500.12110/paper_16643224_v9_n_p2190_Corapi |
| Aporte de: |
Ejemplares similares
-
Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity
por: Corapi, E., et al. -
Vascular galectins: Regulators of tumor progression and targets for cancer therapy
Publicado: (2013) -
Vascular galectins: Regulators of tumor progression and targets for cancer therapy
por: Thijssen, V.L., et al. -
Overcoming the hurdles of tumor immunity by targeting regulatory pathways in innate and adaptive immune cells
por: Croci Russo, Diego Omar, et al.
Publicado: (2010) -
Overcoming the hurdles of tumor immunity by targeting regulatory pathways in innate and adaptive immune cells
por: Zwirner, N.W., et al.